This FAQ answers common questions about acne fulminans with evidence-based guidance for decisions and next steps. Acne fulminans is the most severe form of acne, with sudden painful hemorrhagic nodules that rapidly ulcerate, crust, and often leave extensive disfiguring scars. The Cutis/MDedge expert report describes this ulcerating and crusting course the expert report on acne fulminans. It most often follows 1-2 years of milder acne in teen boys.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who develops it and how does it begin?
- How does it differ from acne conglobata?
- What body-wide symptoms and test results occur?
- What can trigger a flare?
- How is it treated and what are the limits?
Who develops it and how does it begin?
It mainly affects adolescent males aged 13-22. It accounts for under 1% of acne cases. Most patients have had mild-to-moderate acne for 1-2 years before the sudden flare.
The shift is abrupt and painful. Prior pimples give way to bleeding nodules that ulcerate and crust. Rapid pain plus ulceration separates this flare from usual teenage breakouts.
How does it differ from acne conglobata?
Acne conglobata builds gradually and stays limited to skin. Acne fulminans erupts suddenly with ulcerating, necrotic lesions plus systemic upset and high white-cell counts. StatPearls makes this sudden-versus-gradual distinction the StatPearls review of severe acne.
Use the pattern to act. Gradual deep lumps without fever point toward conglobata. Sudden ulcers plus fever, joint pain, or feeling ill point toward fulminans and urgent care.
What body-wide symptoms and test results occur?
Patients commonly develop fever, fatigue, weight loss, joint pain, muscle pain, and bone pain. A Medscape summary of a 2023 review of 212 patients reports fever in about 80% of systemic cases. It reports musculoskeletal signs in about 88% of systemic cases.
Laboratory and imaging findings often show high white cells, high inflammation markers, anemia, and urine protein. A Cleveland Clinic case report notes inflammatory bone lesions of the sternum, collarbones, and sacroiliac joints. Chest pain or joint pain with severe acne needs prompt medical evaluation.
What can trigger a flare?
StatPearls lists high-dose isotretinoin initiation, elevated testosterone, testosterone therapy, and anabolic-steroid use as reported triggers. These hormones increase sebum and Cutibacterium acnes density. More oil and bacteria can fuel severe inflammation.
A flare can follow soon after starting a risky drug or dose. Tell the dermatologist about acne pills, testosterone products, gym supplements, and recent dose changes. Do not start, stop, or adjust prescription acne treatment on your own.
How is it treated and what are the limits?
Evidence-based management starts with prednisone alone to calm inflammation. The 2017 MDedge guideline summary recommends prednisone 0.5-1 mg/kg/day alone for at least 2-4 weeks the guideline summary on acne fulminans treatment. It then adds low-dose isotretinoin with overlapping steroids.
The practical sequence is: No large randomized trials exist for acne fulminans. A PM360 guideline summary notes that recommendations rest on case series and reports. Treatment therefore requires dermatology supervision, individualized tapering, and scarring follow-up.
- take prednisone alone for at least 2-4 weeks
- add isotretinoin 0.1 mg/kg/day while continuing steroids for at least 4 weeks
- avoid antibiotics as the sole treatment
- taper steroids individually under dermatology supervision and plan scarring follow-up